A Federal Circuit court ruled that Abbott (NYSE:ABT) must face patent infringement claims going back to St. Jude Medical. Abbott acquired St. Jude Medical for $25 billion in 2017. A year ago, it won a patent dispute over the method for using a double catheter in heart failure patients. Niazi Licensing sued St. Jude in […]